Greif enters its fiscal fourth-quarter report with an unusual split personality. Last quarter management raised the floor on full-year EBITDA for the first time this year, pointed to its first sequential demand improvement in several quarters and announced a bigger dividend and a fresh buyback. Yet it also trimmed its free cash flow outlook and kept refusing to call a bottom in the industrial markets it serves. The stock has drifted lower since, so this report has to show that the earnings momentum is real and that the cash shortfall was a timing issue rather than a warning sign.

Wall Street is looking for earnings of $1.09 per share on revenue of about $1.10 billion. That is a clear step down from the $1.61 and $1.17 billion posted last quarter, which partly reflects seasonality and the softer quarter that typically closes Greif's year. The more useful yardstick is the company's full-year adjusted EBITDA range of $615 million to $635 million, raised from a $610 million low end after the second quarter. Because this quarter completes the year, the result will settle where Greif lands inside that band. A finish toward the upper half would confirm last quarter's upgrade was conservative. Anything near the bottom would suggest the raise was more about locking in a strong third quarter than about improving trends.

The engine of the story has been self-help rather than demand. Cost savings reached a $90 million annual run rate early in the third quarter, ahead of schedule, and the company still targets $120 million for fiscal 2027. That program drove a 260 basis point year-over-year margin gain last quarter. Investors should look for evidence that savings are still accumulating and for any update on the path to the 2027 target, since that is where next year's earnings growth must come from if end markets stay weak. The modest volume improvements management flagged, including polymer volumes up 1.5% and high-single-digit total volume growth in the standalone closures business, need to hold. A relapse would put the entire burden back on cost cuts.

Cash flow is the swing factor. Greif cut its free cash flow outlook to $305 million to $325 million because it carried expensive inventory to protect supply and absorbed restructuring costs. Management said that inventory should normalize in the fourth quarter. If working capital unwinds as promised, the cut looks like a timing blip. If inventory stays elevated, it would challenge the assertion that the business is converting its earnings improvement into cash, which also funds the expanded buyback and the new Amboplast acquisition in Spain. Fiber margins deserve scrutiny too. They fell last quarter as costs rose ahead of price increases, and the second $60 per ton increase on uncoated recycled board has not been recognized by the RISI index, leaving some contract pricing in doubt. Resin volatility and the roughly $20 million Middle East drag remain additional variables.

Sentiment has warmed from modestly bearish before the last report to slightly bullish now, but the stock has not followed. Shares are down about 4.9% since the last report while the S&P 500 gained 2.7%. At $82.27, the stock sits in the lower half of its post-earnings range of $77.24 to $90.57, though still comfortably above its 200-day moving average of $74.19 after a sharp run in the prior quarter. That suggests the market has paused rather than turned against the story.

The central question is whether Greif can show that its earnings gains are durable and cash-generative. A year-end EBITDA result in the upper half of guidance, visible inventory relief and continued cost-savings progress would keep the self-help narrative intact. Weak cash conversion or slipping fiber margins would revive doubts that last quarter's optimism got ahead of the underlying markets.